Association Between Metabolic Control and Cardiometabolic Risk in Children With Type 1 Diabetes.

University of Ljubljana, Faculty of Medicine1 site in 1 country150 target enrollmentJanuary 5, 2018

ConditionsType1 Diabetes Mellitus Metabolic Complication

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Type1 Diabetes Mellitus
Sponsor: University of Ljubljana, Faculty of Medicine
Enrollment: 150
Locations: 1
Primary Endpoint: Carotid Intima-Media Thickness
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To access the relationship between metabolic control of children and adolescents with type 1 diabetes and cardiometabolic risk through noninvasive imaging modalities to assess the early vasculature changes.

Registry

clinicaltrials.gov

Start Date

January 5, 2018

End Date

November 30, 2019

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Ljubljana, Faculty of Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Type 1 diabetes for more than 0.5 year
•Age ≥ 10 years up to 25 years (inclusive)
•The subject/carer is willing to follow study specific instructions

Exclusion Criteria

•Youth with maturity-onset diabetes of the young, hybrid, other, or missing type
•Any significant diseases / conditions including psychiatric disorders and substance abuse that in the opinion of the investigator is likely to affect the subject's ability to complete the study
•Current use of the following medications: medications that are used to lower blood glucose such as Pramlintide, Metformin and GLP-1 analogs. Beta blockers, glucocorticoids and other medications, which in the judgment of the investigator would be a contraindication to participation in the study (Anticoagulant therapy e.g. Plavix, LMW heparin, Coumadin, Immunosuppressant therapy)